within Pharmacolibrary.Drugs.ATC.C;

model C05AE03
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.4,
    Cl             = 0.64 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 60 / 1000000,
    adminCount     = 1,
    Vd             = 0.0036,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.022500000000000003,
    Tlag           = 10.200000000000001
  );

  annotation(Documentation(
    info ="<html><body><p>Diltiazem is a calcium channel blocker used primarily for the treatment of hypertension, angina pectoris, and certain types of arrhythmias. It is an approved and widely used medication today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers after single oral immediate-release dose.</p><h4>References</h4><ol><li><p>Kinney, EL, et al., &amp; Zelis, R (1981). The pharmacokinetics and pharmacology of oral diltiazem in normal volunteers. <i>Journal of clinical pharmacology</i> 21(8-9) 337–342. DOI:<a href=&quot;https://doi.org/10.1002/j.1552-4604.1981.tb01778.x&quot;>10.1002/j.1552-4604.1981.tb01778.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7276227/&quot;>https://pubmed.ncbi.nlm.nih.gov/7276227</a></p></li><li><p>Murata, K, et al., &amp; Samejima, M (1989). Pharmacokinetics of an oral sustained-release diltiazem preparation. <i>Journal of pharmaceutical sciences</i> 78(11) 960–963. DOI:<a href=&quot;https://doi.org/10.1002/jps.2600781116&quot;>10.1002/jps.2600781116</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2621582/&quot;>https://pubmed.ncbi.nlm.nih.gov/2621582</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end C05AE03;
